• 1
    Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86: 16411648.
  • 2
    Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med 1993; 328: 18281835.
  • 3
    Ramadori G, Veit T, Dienes HP, Knittel T, Rieder H. Meyer zum Buschenfelde K-H. Expression of the gene of the a-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol 1990; 59: 349357.
  • 4
    Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193203.
  • 5
    Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990; 11: 599605.
  • 6
    Bachem MG, Meyer D, Melchior R, Sell K-M, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast like cells: a potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992; 89: 1927.
  • 7
    Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F. Appearance of α-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver 1991; 11: 100105.
  • 8
    Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, Maruo F. Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol 1991; 164: 273278.
  • 9
    Jézéquel AM, Ballardini G, Mancini R, Paolucci F, Bianchi FB, Orlandi F. Modulation of extracellular matrix components during dimethylnitrosamine-induced cirrhosis. J Hepatol 1990; 11: 206214.
  • 10
    Czaja MJ, Weiner FR, Flanders KG, Giamdrone M-A, Wind R, Biempica L, Zern MA. In vitro and in vivo association of transforming growth factorβ with hepatic fibrosis. J Cell Biol 1989; 108: 24772482.
  • 11
    Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987; 262: 64436446.
  • 12
    Raghow R, Postlethwaite E, Keski-Oja J, Moses HL, Rang AH. Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 1987; 79: 12851288.
  • 13
    Nakatsukasa H, Nagy P, Evarts RP, Hsia C-C, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-β1 and procollagen types I, III and IV in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85: 18331843.
  • 14
    Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. N Engl J Med 1991; 324: 933940.
  • 15
    Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K. et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440443.
  • 16
    Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H. et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967973.
  • 17
    Matsumoto K, Nakamura T. Hepatocyte growth factor: Molecular structure, roles in liver regeneration, and other biological functions. Grit Rev Oncog 1992; 3: 2754.
  • 18
    Higashio K, Shima N, Goto M, Itagaki Y, Nagao M, Yasuda H, Morinaga T. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem Biophys Res Commun 1990; 170: 397404.
  • 19
    Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T. et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993; 18: 14431449.
  • 20
    Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A, Higashio K. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun 1991; 180: 11511158.
  • 21
    Shima N, Tsuda E, Goto M, Yano K, Hayasaka H, Ueda M, Higashio K. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Biochem Biophys Res Commun 1994; 200: 808815.
  • 22
    Clement B, Loréal O, Levavasseur F, Guillouzo A. New challenges in hepatic fibrosis. J Hepatol 1993; 18: 14.
  • 23
    Jézéquel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 1987; 5: 174181.
  • 24
    Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967; 19: 249255.
  • 25
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156159.
  • 26
    Genovese C, Rowe D, Kream B. Construction of DNA sequences complementary to rat αl and rat α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,24-dihydroxyvitamin D. Biochemistry 1984; 23: 62106216.
  • 27
    Frankel FR, Hsu C-YJ, Myers JC, Lin E, Lyttle CR, Komm B, Mohn K. Regulation of alpha2 (I), alphal (III), and alpha2 (V) collagen mRNAs by estradiol in the immature rat uterus. DNA 1988; 7: 347354.
  • 28
    Wood L, Theriaut N, Vogeli G. cDNA clones completing the nucleotide and derived amino acid sequence of the alpha 1 chain of basement membrane (type IV) collagen from mouse. FEBS Lett 1988; 227: 58.
  • 29
    Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acids Res 1990; 18: 3059.
  • 30
    Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 24852502.
  • 31
    Li H, Choudhary SK, Milner DJ, Munir MI, Kuisk IR, Capetanaki Y. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J Cell Biol 1994; 124: 827841.
  • 32
    McHugh KM, Lessard JL. The nucleotide sequence of a rat vascular smooth muscle alpha-actin cDNA. Nucleic Acids Res 1988; 16: 4167.
  • 33
    Ala-Kokko L, Pihlajaniemi T, Meyers JC, Kivirikko KI, Savolainen ER. Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J 1987; 244: 7579.
  • 34
    Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985; 133: 10421050.
  • 35
    Russell WE, Coffey RJ, Quellette AJ, Moses HL. Type (β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988; 85: 51265130.
  • 36
    Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988; 85: 15391543.
  • 37
    Maher JJ. Cell-specific expression of hepatocyte growth factor in liver. J Clin Invest 1993; 91: 22442252.